Package 65162-771-03

Brand: montelukast sodium

Generic: montelukast
NDC Package

Package Facts

Identity

Package NDC 65162-771-03
Digits Only 6516277103
Product NDC 65162-771
Product ID 65162-771_ed8a8093-3cde-44cf-9bdc-c8bc5fb9909c
Description

30 TABLET, CHEWABLE in 1 BOTTLE (65162-771-03)

Marketing

Marketing Status
Marketed Since 2020-09-04
Brand montelukast sodium
Generic montelukast
Sample Package No

Linked Drug Pages (1)

Montelukast Sodium ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ed8a8093-3cde-44cf-9bdc-c8bc5fb9909c", "openfda": {"unii": ["U1O3J18SFL"], "rxcui": ["242438", "311759"], "spl_set_id": ["bcd49102-a21c-4628-a322-6cdd934e7f09"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, CHEWABLE in 1 BOTTLE (65162-771-03)", "package_ndc": "65162-771-03", "marketing_start_date": "20200904"}], "brand_name": "Montelukast Sodium", "product_id": "65162-771_ed8a8093-3cde-44cf-9bdc-c8bc5fb9909c", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Leukotriene Receptor Antagonist [EPC]", "Leukotriene Receptor Antagonists [MoA]"], "product_ndc": "65162-771", "generic_name": "Montelukast", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Montelukast Sodium", "active_ingredients": [{"name": "MONTELUKAST SODIUM", "strength": "4 mg/1"}], "application_number": "ANDA205107", "marketing_category": "ANDA", "marketing_start_date": "20200904", "listing_expiration_date": "20261231"}